prefilled self-administered high viscosity injectables

Prefilled Self-administered High Viscosity Injectables

$3,850.00

Monoclonal antibodies, perhaps the most significant high viscosity drug category in terms of therapeutic and commercial importance, typically possess viscosities that are well above the normal limits of subcutaneous injection devices and techniques. Without a technical solution, these high viscosity drugs are formulated and supplied for infusion, a trend that threatens to put additional pressure on patient logistics and healthcare economics. Drug developers and device designers are increasingly working in collaboration to address the goal of subcutaneous administration of high viscosity injectables.

More information HERE

Category:

Description

Growth in Prefilled Self-administered High Viscosity Injectables is being driven by advances in biotechnology and host-vector engineering – advances that have led to a steady stream of biologics for a number of ailments and conditions. These powerful drugs come with a high cost-per-dose and the risk of significant side effects – factors that place an elevated emphasis on administration efficiency, safety and reliability. Many drugs in this class are characterized by physical properties and sensitivities that challenge the drug commercialization ecosystem.

 

More information HERE

Related products